Antimicrobial technology

An antimicrobial technology from Engelhard Corp. has been granted registration by the U.S. Environmental Protection Agency (EPA) for use against tuberculosis (TB) and other animal pathogens in veterinary applications.Engelhards Aseptrol technology can be tailored to release chlorine dioxide, a potent germ killer, at precise rates and in controlled concentrations when it comes in contact with water or moisture in the air.Chlorine dioxide has been used in industrial applications for many years, but until development of Engelhards patented, controlled-release technology, the powerful biocide could not be incorporated into a stable, easy-to-use form, such as dry powder.The new registration authorizes Aseptrol for use against TB, canine parvovirus, mouse hepatitis virus (MHV), sialodacryoadenitis virus (SDAV), murine parainfluenza virus type 1 (Sendai), mouse parvovirus type 1 (MPV-1), and minute virus of mice (MVM) in animal rearing and confinement facilities, such as kennels and cages. The technology is at the heart of Quip Laboratories MB-10 tablets, which are designed for disinfecting animal confinement areas and hard surfaces, and for eliminating odors from animal waste. Engelhard also is conducting efficacy tests to secure EPA registration for use of Aseptrol against other animal pathogens, including the Norwalk virus, foot and mouth disease and Newcastle virus. Available in sachet and tablet form, Aseptrol is being used in a widening range of consumer and industrial purification and deodorization applications. Last year the technology received EPA registration for use in purifying drinking water.

For fastest response call or visit the Web site at www.engelhard.com.